编码疟疾传播阻断疫苗靶抗原Pfs230D1M和Pvs230D1的DNA疫苗产生不同的免疫原性结果
本研究构建了编码Pfs230D1M和Pvs230D1的DNA疫苗,在小鼠中经体内电穿孔递送后并排比较免疫原性。两种疫苗均诱导有效抗体应答;抗Pfs230D1M IgG在标准膜喂养试验中显示补体依赖的强剂量依赖性传播阻断活性,而抗Pvs230D1 IgG在直接膜喂养试验中仅显示中等传播阻断活性。
要点
- 编码Pfs230D1M和Pvs230D1的DNA疫苗经体内电穿孔均在小鼠中诱导有效抗体应答。
- 抗Pfs230D1M IgG在标准膜喂养试验中显示补体依赖的强剂量依赖性传播阻断活性。
- 抗Pvs230D1 IgG在直接膜喂养试验中仅显示中等传播阻断活性。
核心结论
- 结果表明Pfs230D1M和Pvs230D1 DNA疫苗均有潜力作为抗恶性疟原虫和间日疟原虫的传播阻断疫苗候选,并为未来优化基于Pfs230和Pvs230的DNA疫苗效力提供了依据。
研究设计与样本
- 本研究构建编码Pfs230D1M和Pvs230D1的DNA疫苗,在小鼠中经体内电穿孔递送并进行并排免疫原性比较。
主要发现
- 编码Pfs230D1M和Pvs230D1的DNA疫苗经体内电穿孔均在小鼠中诱导有效抗体应答。
- 抗Pfs230D1M IgG在标准膜喂养试验中显示补体依赖的强剂量依赖性传播阻断活性。
- 抗Pvs230D1 IgG在使用多名间日疟原虫感染供者血液的直接膜喂养试验中仅显示中等传播阻断活性。
- Pfs230D1M DNA疫苗诱导的抗体显示强IgG1偏倚和较高亲和力,而Pvs230D1 DNA疫苗诱导的抗体显示IgG1/IgG2平衡应答和较低抗体亲和力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transmission-blocking vaccines (TBVs) targeting sexual-stage antigens represent a critical tool for malaria control and elimination through inhibiting parasite development within mosquitoes. P230, displayed on the surface of gametocytes and gametes, plays a crucial role in gamete fertilization and is one of the leading TBV candidates for both Plasmodium falciparum and P. vivax. Antibodies induced by immunization with a recombinant P. falciparum protein encompassing a portion of N-terminal prodomain and domain 1 (Pfs230D1M) have revealed strong transmission-reducing activity (TRA) in preclinical studies. While a recombinant Pvs230D1, the P. vivax homolog of Pfs230D1M, has not been evaluated in preclinical immunogenicity studies, both Pfs230D1M and Pvs230D1 are currently scheduled for evaluation in clinical trials. In this study, we developed DNA vaccines encoding Pfs230D1M and Pvs230D1 for a side-by-side comparison of their immunogenicity. Potent antibody responses were induced in mice immunized with each DNA vaccine delivered by in vivo electroporation (EP). Anti-Pfs230D1M IgG exhibited potent dose-dependent TRA in a complement-dependent manner in standard membrane feeding assays (SMFA). In contrast, anti-Pvs230D1 IgG exhibited only moderate TRA in direct membrane feeding assay (DMFA) using blood from multiple P. vivax-infected donors. Antibodies induced by the Pfs230D1M DNA vaccine revealed a strong IgG1 bias and higher avidity as compared to a balanced IgG1/IgG2 response and lower antibody avidity by the Pvs230D1 DNA vaccine. Our results demonstrate the potential of both Pfs230D1M and Pvs230D1 DNA vaccines as TBV candidates against P. falciparum and P. vivax, and provide a rationale for future optimization to enhance the efficacy of DNA vaccines based on Pfs230 and Pvs230.
引用
- Cao Y, da Silva Araujo M, Lorang CG, et al. Distinct immunogenicity outcomes of DNA vaccines encoding malaria transmission-blocking vaccine target antigens Pfs230D1M and Pvs230D1. Vaccine. 2025. PMID: 39787798. doi:10.1016/j.vaccine.2024.126696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。